Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Kay

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Psychiatry Research|November 1, 1990
Dilapidation in schizophrenia: relationship to negative syndrome and prefrontal impairmentA E Merriam, S R Kay, L A Opler, et al.
Journal of Clinical Psychopharmacology|October 1, 1989
Ascorbic acid action in neuroleptic-associated amenorrheaJ D Kanofsky, S R Kay, J P Lindenmayer, et al.
The International Journal of Neuroscience|December 1, 1991
Risk factors for neuroleptic-induced movement disordersR Sandyk, S R Kay, G I Awerbuch, et al.
The Journal of Nervous and Mental Disease|August 1, 1990
The Positive and Negative Syndrome Scale--Spanish adaptationS R Kay, A Fiszbein, M Vital-Herne, et al.
The American Journal of Psychiatry|July 1, 1988
Ascorbic acid and dopamine activityJ D Kanofsky, S R Kay, J P Lindenmayer, et al.
The American Journal of Psychiatry|June 1, 1987
The changing presentation of catatoniaS R Kay, D Kanofsky, J P Lindenmayer, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1987
Catatonic schizophrenia and negative symptomsJ D Kanofsky, S R Kay, J P Lindenmayer, et al.
The Journal of Nervous and Mental Disease|October 1, 1990
Significance of cocaine history in schizophreniaS Sevy, S R Kay, L A Opler, et al.
Schizophrenia Research|October 1, 1990
Negative schizophrenic symptoms are associated with backward masking vulnerabilityA E Merriam, S R Kay, R U Weiner, et al.
Archives of General Psychiatry|August 1, 1989
Information processing deficit in schizophrenia: a frontal lobe sign?A E Merriam, S R Kay, L A Opler, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Psychiatry Research|November 1, 1990
Dilapidation in schizophrenia: relationship to negative syndrome and prefrontal impairmentA E Merriam, S R Kay, L A Opler, et al.
Journal of Clinical Psychopharmacology|October 1, 1989
Ascorbic acid action in neuroleptic-associated amenorrheaJ D Kanofsky, S R Kay, J P Lindenmayer, et al.
The International Journal of Neuroscience|December 1, 1991
Risk factors for neuroleptic-induced movement disordersR Sandyk, S R Kay, G I Awerbuch, et al.
The Journal of Nervous and Mental Disease|August 1, 1990
The Positive and Negative Syndrome Scale--Spanish adaptationS R Kay, A Fiszbein, M Vital-Herne, et al.
The American Journal of Psychiatry|July 1, 1988
Ascorbic acid and dopamine activityJ D Kanofsky, S R Kay, J P Lindenmayer, et al.
The American Journal of Psychiatry|June 1, 1987
The changing presentation of catatoniaS R Kay, D Kanofsky, J P Lindenmayer, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1987
Catatonic schizophrenia and negative symptomsJ D Kanofsky, S R Kay, J P Lindenmayer, et al.
The Journal of Nervous and Mental Disease|October 1, 1990
Significance of cocaine history in schizophreniaS Sevy, S R Kay, L A Opler, et al.
Schizophrenia Research|October 1, 1990
Negative schizophrenic symptoms are associated with backward masking vulnerabilityA E Merriam, S R Kay, R U Weiner, et al.
Archives of General Psychiatry|August 1, 1989
Information processing deficit in schizophrenia: a frontal lobe sign?A E Merriam, S R Kay, L A Opler, et al.
Pageof 12